Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 3/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6149503 | 0.92 | MRGPRX4 (0.41) | HIF1AMRGPRX4OPRL1THRBCYP11B1 | |
| SCHEMBL6149506 | 0.92 | MRGPRX4 (0.41) | HIF1AMRGPRX4OPRL1THRBCYP11B1 | |
| SCHEMBL5076445 | 0.89 | KDM4E (0.41) | HIF1AMRGPRX4KDM4EHTTMAPT | |
| SCHEMBL8165202 | 0.89 | HIF1A (0.46) | HIF1AOPRL1PPARGPPARDPPARA | |
| SCHEMBL8165199 | 0.89 | HIF1A (0.46) | HIF1AOPRL1PPARGPPARDPPARA | |
| SCHEMBL5080342 | 0.85 | HIF1A (0.37) | HIF1AKDM4E | |
| SCHEMBL5080480 | 0.85 | ALDH1A1 (0.41) | HIF1AOPRL1MAPT | |
| SCHEMBL5080584 | 0.84 | HIF1A (0.63) | HIF1AMRGPRX4OPRL1THRBPPARD | |
| SCHEMBL5074553 | 0.83 | HIF1A (0.39) | HIF1AMRGPRX4HTT | |
| SCHEMBL8158936 | 0.82 | MRGPRX4 (0.63) | MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435844-B2 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2008-10-14 | — | — | US | disclosed |
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | DDT, RYR1, TPMT | HIF1A 4554/4885MRGPRX4 989/4885OPRL1 3733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.